Similarly, reduction in growth hormone signalling by liver-specific knockout of Stat5 leads to steatohepatitis, glucose intolerance, late onset obesity, impaired liver regeneration and insulin resistance (Baik et al. 2011). Here, GH1 is linked to Glucose intolerance.